Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program

Acta Paediatr Scand. 1981 Jan;70(1):73-9. doi: 10.1111/j.1651-2227.1981.tb07176.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / epidemiology
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infant
  • Injections, Spinal
  • Leucovorin / administration & dosage
  • Leukemia, Lymphoid / drug therapy*
  • Leukemia, Lymphoid / epidemiology
  • Male
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use*
  • Neoplasm Recurrence, Local
  • Norway
  • Pilot Projects

Substances

  • Antineoplastic Agents
  • Leucovorin
  • Methotrexate